title: Calcium antagonists and cardiovascular prognosis: a homogeneous group?
authors.affiliation: New York Hospital-Cornell Medical Center, New York City 10021, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Laragh
authors.forename: C
authors.initials: C
authors.lastname: Held
authors.forename: F
authors.initials: F
authors.lastname: Messerli
authors.forename: C
authors.initials: C
authors.lastname: Pepine
authors.forename: P
authors.initials: P
authors.lastname: Sleight
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004095:Dihydropyridines / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D014700:Verapamil; D004110:Diltiazem